Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial
Lifestyle interventions remain the cornerstone therapy for non-alcoholic fatty liver disease (NAFLD). This randomised controlled single-blind clinical trial investigated the effect of Mediterranean diet (MD) or Mediterranean lifestyle, along with weight loss, in NAFLD patients. In all, sixty-three o...
Gespeichert in:
| Veröffentlicht in: | British journal of nutrition 2018-07, Vol.120 (2), p.164-175 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 175 |
|---|---|
| container_issue | 2 |
| container_start_page | 164 |
| container_title | British journal of nutrition |
| container_volume | 120 |
| creator | Katsagoni, Christina N Papatheodoridis, George V Ioannidou, Panagiota Deutsch, Melanie Alexopoulou, Alexandra Papadopoulos, Nikolaos Papageorgiou, Maria-Vasiliki Fragopoulou, Elizabeth Kontogianni, Meropi D |
| description | Lifestyle interventions remain the cornerstone therapy for non-alcoholic fatty liver disease (NAFLD). This randomised controlled single-blind clinical trial investigated the effect of Mediterranean diet (MD) or Mediterranean lifestyle, along with weight loss, in NAFLD patients. In all, sixty-three overweight/obese patients (50 (sd 11) years, BMI=31·8 (sd 4·5) kg/m2, 68 % men) with ultrasonography-proven NAFLD (and elevated alanine aminotransferase (ALT) and/or γ-glutamyl transpeptidase (GGT) levels) were randomised to the following groups: (A) control group (CG), (B) Mediterranean diet group (MDG) or (C) Mediterranean lifestyle group (MLG). Participants of MDG and MLG attended seven 60-min group sessions for 6 months, aiming at weight loss and increasing adherence to MD. In the MLG, additional guidance for increasing physical activity and improving sleep habits were given. Patients in CG received only written information for a healthy lifestyle. At the end of 6 months, 88·8 % of participants completed the study. On the basis of intention-to-treat analysis, both MDG and MLG showed greater weight reduction and higher adherence to MD compared with the CG (all P |
| doi_str_mv | 10.1017/S000711451800137X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2060871054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2061989214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-7f4cc782ddd32d5c98de5700238b0b429425a452c34982f6736d2b3240acb0a13</originalsourceid><addsrcrecordid>eNplkc1u1DAUhS0EokPhAdggS2xYELj-SZywQxU_lVp1AUjsIsd2NK4ce7A9g-bpeDVuaMuiXfna5ztHR76EvGTwjgFT778BgGJMtqwHYEL9fEQ2TKq24V3HH5PNKjerfkKelXKN157B8JSc8GGQSnC-IX_Ol11OB7e4WAv1kZrgozc6ULPVWZvqsi_Vm0LTTHe6-n_cb1-3NKbY6GDSNgVv6KxrPdLgDy5T64vTxb2lekY_1RGDcTig16dIJ9QsxaFuHb101qOWdXTIBT-7Uo_BfaCa4ptNi19hk2LNKYR1vCtYs9fhOXky61Dci9vzlPz4_On72dfm4urL-dnHi8ZIDrVRszRG9dxaK7htzdBb1yoALvoJJskHyVstW26EHHo-d0p0lk-CS9BmAs3EKXlzk4u_9WuPHUcsZlwI2Dvty8ihg14xaCWir--h12mfI7ZbKTb0A2crxW4ok1Mp2c3jLvtF5-PIYFy3Oz7YLnpe3Sbvp8XZ_467dYq_v6ujWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2061989214</pqid></control><display><type>article</type><title>Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><source>Cambridge University Press Journals Complete</source><creator>Katsagoni, Christina N ; Papatheodoridis, George V ; Ioannidou, Panagiota ; Deutsch, Melanie ; Alexopoulou, Alexandra ; Papadopoulos, Nikolaos ; Papageorgiou, Maria-Vasiliki ; Fragopoulou, Elizabeth ; Kontogianni, Meropi D</creator><creatorcontrib>Katsagoni, Christina N ; Papatheodoridis, George V ; Ioannidou, Panagiota ; Deutsch, Melanie ; Alexopoulou, Alexandra ; Papadopoulos, Nikolaos ; Papageorgiou, Maria-Vasiliki ; Fragopoulou, Elizabeth ; Kontogianni, Meropi D</creatorcontrib><description>Lifestyle interventions remain the cornerstone therapy for non-alcoholic fatty liver disease (NAFLD). This randomised controlled single-blind clinical trial investigated the effect of Mediterranean diet (MD) or Mediterranean lifestyle, along with weight loss, in NAFLD patients. In all, sixty-three overweight/obese patients (50 (sd 11) years, BMI=31·8 (sd 4·5) kg/m2, 68 % men) with ultrasonography-proven NAFLD (and elevated alanine aminotransferase (ALT) and/or γ-glutamyl transpeptidase (GGT) levels) were randomised to the following groups: (A) control group (CG), (B) Mediterranean diet group (MDG) or (C) Mediterranean lifestyle group (MLG). Participants of MDG and MLG attended seven 60-min group sessions for 6 months, aiming at weight loss and increasing adherence to MD. In the MLG, additional guidance for increasing physical activity and improving sleep habits were given. Patients in CG received only written information for a healthy lifestyle. At the end of 6 months, 88·8 % of participants completed the study. On the basis of intention-to-treat analysis, both MDG and MLG showed greater weight reduction and higher adherence to MD compared with the CG (all P<0·05) at the end of intervention. In addition, MLG increased vigorous exercise compared with the other two study groups (P<0·001) and mid-day rest/naps compared with CG (P=0·04). MLG showed significant improvements in ALT levels (i.e. ALT<40 U/l (P=0·03) and 50 % reduction of ALT levels (P=0·009)) and liver stiffness (P=0·004) compared with CG after adjusting for % weight loss and baseline values. MDG improved only liver stiffness compared with CG (P<0·001) after adjusting for the aforementioned variables. Small changes towards the Mediterranean lifestyle, along with weight loss, can be a treatment option for patients with NAFLD.</description><identifier>ISSN: 0007-1145</identifier><identifier>EISSN: 1475-2662</identifier><identifier>DOI: 10.1017/S000711451800137X</identifier><identifier>PMID: 29947322</identifier><language>eng</language><publisher>England: Cambridge University Press</publisher><subject>Alanine ; Alanine transaminase ; Alcohol use ; Body weight ; Body weight loss ; Clinical trials ; Diabetes ; Diet ; Disease control ; Enzymes ; Evidence-based medicine ; Exercise ; Fatty liver ; Hepatitis ; Histology ; Insulin resistance ; Laboratories ; Lifestyles ; Liver ; Liver diseases ; Metabolic syndrome ; Mortality ; Motivation ; Overweight ; Patients ; Physical activity ; Physical fitness ; Randomization ; Sleep ; Stiffness ; Ultrasonic imaging ; Ultrasound ; Weight loss ; Weight reduction ; γ-Glutamyltransferase</subject><ispartof>British journal of nutrition, 2018-07, Vol.120 (2), p.164-175</ispartof><rights>The Authors 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-7f4cc782ddd32d5c98de5700238b0b429425a452c34982f6736d2b3240acb0a13</citedby><cites>FETCH-LOGICAL-c420t-7f4cc782ddd32d5c98de5700238b0b429425a452c34982f6736d2b3240acb0a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29947322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katsagoni, Christina N</creatorcontrib><creatorcontrib>Papatheodoridis, George V</creatorcontrib><creatorcontrib>Ioannidou, Panagiota</creatorcontrib><creatorcontrib>Deutsch, Melanie</creatorcontrib><creatorcontrib>Alexopoulou, Alexandra</creatorcontrib><creatorcontrib>Papadopoulos, Nikolaos</creatorcontrib><creatorcontrib>Papageorgiou, Maria-Vasiliki</creatorcontrib><creatorcontrib>Fragopoulou, Elizabeth</creatorcontrib><creatorcontrib>Kontogianni, Meropi D</creatorcontrib><title>Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial</title><title>British journal of nutrition</title><addtitle>Br J Nutr</addtitle><description>Lifestyle interventions remain the cornerstone therapy for non-alcoholic fatty liver disease (NAFLD). This randomised controlled single-blind clinical trial investigated the effect of Mediterranean diet (MD) or Mediterranean lifestyle, along with weight loss, in NAFLD patients. In all, sixty-three overweight/obese patients (50 (sd 11) years, BMI=31·8 (sd 4·5) kg/m2, 68 % men) with ultrasonography-proven NAFLD (and elevated alanine aminotransferase (ALT) and/or γ-glutamyl transpeptidase (GGT) levels) were randomised to the following groups: (A) control group (CG), (B) Mediterranean diet group (MDG) or (C) Mediterranean lifestyle group (MLG). Participants of MDG and MLG attended seven 60-min group sessions for 6 months, aiming at weight loss and increasing adherence to MD. In the MLG, additional guidance for increasing physical activity and improving sleep habits were given. Patients in CG received only written information for a healthy lifestyle. At the end of 6 months, 88·8 % of participants completed the study. On the basis of intention-to-treat analysis, both MDG and MLG showed greater weight reduction and higher adherence to MD compared with the CG (all P<0·05) at the end of intervention. In addition, MLG increased vigorous exercise compared with the other two study groups (P<0·001) and mid-day rest/naps compared with CG (P=0·04). MLG showed significant improvements in ALT levels (i.e. ALT<40 U/l (P=0·03) and 50 % reduction of ALT levels (P=0·009)) and liver stiffness (P=0·004) compared with CG after adjusting for % weight loss and baseline values. MDG improved only liver stiffness compared with CG (P<0·001) after adjusting for the aforementioned variables. Small changes towards the Mediterranean lifestyle, along with weight loss, can be a treatment option for patients with NAFLD.</description><subject>Alanine</subject><subject>Alanine transaminase</subject><subject>Alcohol use</subject><subject>Body weight</subject><subject>Body weight loss</subject><subject>Clinical trials</subject><subject>Diabetes</subject><subject>Diet</subject><subject>Disease control</subject><subject>Enzymes</subject><subject>Evidence-based medicine</subject><subject>Exercise</subject><subject>Fatty liver</subject><subject>Hepatitis</subject><subject>Histology</subject><subject>Insulin resistance</subject><subject>Laboratories</subject><subject>Lifestyles</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Metabolic syndrome</subject><subject>Mortality</subject><subject>Motivation</subject><subject>Overweight</subject><subject>Patients</subject><subject>Physical activity</subject><subject>Physical fitness</subject><subject>Randomization</subject><subject>Sleep</subject><subject>Stiffness</subject><subject>Ultrasonic imaging</subject><subject>Ultrasound</subject><subject>Weight loss</subject><subject>Weight reduction</subject><subject>γ-Glutamyltransferase</subject><issn>0007-1145</issn><issn>1475-2662</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNplkc1u1DAUhS0EokPhAdggS2xYELj-SZywQxU_lVp1AUjsIsd2NK4ce7A9g-bpeDVuaMuiXfna5ztHR76EvGTwjgFT778BgGJMtqwHYEL9fEQ2TKq24V3HH5PNKjerfkKelXKN157B8JSc8GGQSnC-IX_Ol11OB7e4WAv1kZrgozc6ULPVWZvqsi_Vm0LTTHe6-n_cb1-3NKbY6GDSNgVv6KxrPdLgDy5T64vTxb2lekY_1RGDcTig16dIJ9QsxaFuHb101qOWdXTIBT-7Uo_BfaCa4ptNi19hk2LNKYR1vCtYs9fhOXky61Dci9vzlPz4_On72dfm4urL-dnHi8ZIDrVRszRG9dxaK7htzdBb1yoALvoJJskHyVstW26EHHo-d0p0lk-CS9BmAs3EKXlzk4u_9WuPHUcsZlwI2Dvty8ihg14xaCWir--h12mfI7ZbKTb0A2crxW4ok1Mp2c3jLvtF5-PIYFy3Oz7YLnpe3Sbvp8XZ_467dYq_v6ujWA</recordid><startdate>20180728</startdate><enddate>20180728</enddate><creator>Katsagoni, Christina N</creator><creator>Papatheodoridis, George V</creator><creator>Ioannidou, Panagiota</creator><creator>Deutsch, Melanie</creator><creator>Alexopoulou, Alexandra</creator><creator>Papadopoulos, Nikolaos</creator><creator>Papageorgiou, Maria-Vasiliki</creator><creator>Fragopoulou, Elizabeth</creator><creator>Kontogianni, Meropi D</creator><general>Cambridge University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7T5</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20180728</creationdate><title>Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial</title><author>Katsagoni, Christina N ; Papatheodoridis, George V ; Ioannidou, Panagiota ; Deutsch, Melanie ; Alexopoulou, Alexandra ; Papadopoulos, Nikolaos ; Papageorgiou, Maria-Vasiliki ; Fragopoulou, Elizabeth ; Kontogianni, Meropi D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-7f4cc782ddd32d5c98de5700238b0b429425a452c34982f6736d2b3240acb0a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alanine</topic><topic>Alanine transaminase</topic><topic>Alcohol use</topic><topic>Body weight</topic><topic>Body weight loss</topic><topic>Clinical trials</topic><topic>Diabetes</topic><topic>Diet</topic><topic>Disease control</topic><topic>Enzymes</topic><topic>Evidence-based medicine</topic><topic>Exercise</topic><topic>Fatty liver</topic><topic>Hepatitis</topic><topic>Histology</topic><topic>Insulin resistance</topic><topic>Laboratories</topic><topic>Lifestyles</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Metabolic syndrome</topic><topic>Mortality</topic><topic>Motivation</topic><topic>Overweight</topic><topic>Patients</topic><topic>Physical activity</topic><topic>Physical fitness</topic><topic>Randomization</topic><topic>Sleep</topic><topic>Stiffness</topic><topic>Ultrasonic imaging</topic><topic>Ultrasound</topic><topic>Weight loss</topic><topic>Weight reduction</topic><topic>γ-Glutamyltransferase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katsagoni, Christina N</creatorcontrib><creatorcontrib>Papatheodoridis, George V</creatorcontrib><creatorcontrib>Ioannidou, Panagiota</creatorcontrib><creatorcontrib>Deutsch, Melanie</creatorcontrib><creatorcontrib>Alexopoulou, Alexandra</creatorcontrib><creatorcontrib>Papadopoulos, Nikolaos</creatorcontrib><creatorcontrib>Papageorgiou, Maria-Vasiliki</creatorcontrib><creatorcontrib>Fragopoulou, Elizabeth</creatorcontrib><creatorcontrib>Kontogianni, Meropi D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katsagoni, Christina N</au><au>Papatheodoridis, George V</au><au>Ioannidou, Panagiota</au><au>Deutsch, Melanie</au><au>Alexopoulou, Alexandra</au><au>Papadopoulos, Nikolaos</au><au>Papageorgiou, Maria-Vasiliki</au><au>Fragopoulou, Elizabeth</au><au>Kontogianni, Meropi D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial</atitle><jtitle>British journal of nutrition</jtitle><addtitle>Br J Nutr</addtitle><date>2018-07-28</date><risdate>2018</risdate><volume>120</volume><issue>2</issue><spage>164</spage><epage>175</epage><pages>164-175</pages><issn>0007-1145</issn><eissn>1475-2662</eissn><abstract>Lifestyle interventions remain the cornerstone therapy for non-alcoholic fatty liver disease (NAFLD). This randomised controlled single-blind clinical trial investigated the effect of Mediterranean diet (MD) or Mediterranean lifestyle, along with weight loss, in NAFLD patients. In all, sixty-three overweight/obese patients (50 (sd 11) years, BMI=31·8 (sd 4·5) kg/m2, 68 % men) with ultrasonography-proven NAFLD (and elevated alanine aminotransferase (ALT) and/or γ-glutamyl transpeptidase (GGT) levels) were randomised to the following groups: (A) control group (CG), (B) Mediterranean diet group (MDG) or (C) Mediterranean lifestyle group (MLG). Participants of MDG and MLG attended seven 60-min group sessions for 6 months, aiming at weight loss and increasing adherence to MD. In the MLG, additional guidance for increasing physical activity and improving sleep habits were given. Patients in CG received only written information for a healthy lifestyle. At the end of 6 months, 88·8 % of participants completed the study. On the basis of intention-to-treat analysis, both MDG and MLG showed greater weight reduction and higher adherence to MD compared with the CG (all P<0·05) at the end of intervention. In addition, MLG increased vigorous exercise compared with the other two study groups (P<0·001) and mid-day rest/naps compared with CG (P=0·04). MLG showed significant improvements in ALT levels (i.e. ALT<40 U/l (P=0·03) and 50 % reduction of ALT levels (P=0·009)) and liver stiffness (P=0·004) compared with CG after adjusting for % weight loss and baseline values. MDG improved only liver stiffness compared with CG (P<0·001) after adjusting for the aforementioned variables. Small changes towards the Mediterranean lifestyle, along with weight loss, can be a treatment option for patients with NAFLD.</abstract><cop>England</cop><pub>Cambridge University Press</pub><pmid>29947322</pmid><doi>10.1017/S000711451800137X</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1145 |
| ispartof | British journal of nutrition, 2018-07, Vol.120 (2), p.164-175 |
| issn | 0007-1145 1475-2662 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2060871054 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry; Cambridge University Press Journals Complete |
| subjects | Alanine Alanine transaminase Alcohol use Body weight Body weight loss Clinical trials Diabetes Diet Disease control Enzymes Evidence-based medicine Exercise Fatty liver Hepatitis Histology Insulin resistance Laboratories Lifestyles Liver Liver diseases Metabolic syndrome Mortality Motivation Overweight Patients Physical activity Physical fitness Randomization Sleep Stiffness Ultrasonic imaging Ultrasound Weight loss Weight reduction γ-Glutamyltransferase |
| title | Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A58%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improvements%20in%20clinical%20characteristics%20of%20patients%20with%20non-alcoholic%20fatty%20liver%20disease,%20after%20an%20intervention%20based%20on%20the%20Mediterranean%20lifestyle:%20a%20randomised%20controlled%20clinical%20trial&rft.jtitle=British%20journal%20of%20nutrition&rft.au=Katsagoni,%20Christina%20N&rft.date=2018-07-28&rft.volume=120&rft.issue=2&rft.spage=164&rft.epage=175&rft.pages=164-175&rft.issn=0007-1145&rft.eissn=1475-2662&rft_id=info:doi/10.1017/S000711451800137X&rft_dat=%3Cproquest_cross%3E2061989214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2061989214&rft_id=info:pmid/29947322&rfr_iscdi=true |